Additional Prognostic Value of SUVmax Measured by F-18 FDG PET/CT over Biological Marker Expressions in Surgically Resected Cervical Cancer Patients

被引:8
|
作者
Yun, Man Soo [1 ,2 ]
Kim, Seong-Jang [2 ,3 ]
Pak, Kyoungjune [3 ]
Lee, Chang Hun [2 ,4 ]
机构
[1] Pusan Natl Univ Hosp, Dept Obstet & Gynecol, Busan 602739, South Korea
[2] Pusan Natl Univ, Biomed Res Inst, Busan, South Korea
[3] Pusan Natl Univ Hosp, Dept Nucl Med, Busan 602739, South Korea
[4] Pusan Natl Univ Hosp, Dept Pathol, Busan 602739, South Korea
关键词
Cervical cancer; SUVmax; Disease-free survival; Biological marker expression; POSITRON-EMISSION-TOMOGRAPHY; GLUCOSE-TRANSPORTER GLUT-1; ENDOTHELIAL GROWTH-FACTOR; SQUAMOUS-CELL CARCINOMAS; CLINICAL-RELEVANCE; PREDICTIVE-VALUE; IX EXPRESSION; TUMOR HYPOXIA; GLUCOSE-TRANSPORTER-1; SURVIVAL;
D O I
10.1159/000438959
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: We compared the prognostic ability of the maximum standardized uptake value (SUVmax) and various biological marker expressions to predict recurrence in patients with surgically resected cervical cancer. Methods: A retrospective review identified 60 patients with cervical cancer who received [F-18]fluorodeoxyglucose positron emission tomography/computed tomography (F-18 FDG PET/CT) at the time of the diagnosis of cancer. The SUVmax, expressions of carbonic an hydrase-IX (CA-IX), glucose transporter 1 (GLUT-1), and vascular endothelial growth factor (VEGF), and known prognostic factors were investigated. Results: The median follow-up time was 22.2 months (range 3.4-43.1 months). Using univariate analyses, the stage (stage II, p = 0.0066), SUVmax (> 6, p = 0.027), parametria I involvement (p < 0.0001), and positivity for CA-IX (p = 0.0191) were associated with recurrences of cervical cancer. With the Cox proportional hazard regression model, the SUVmax was a potent predictor for disease-free survival (DFS). Conclusion: Although CA-IX expression was related to DFS in the current study, the potent predictor for DFS was SUVmax. Therefore, SUVmax is of greater prognostic value than biological marker expression in patients with surgically resected cervical cancer. (C) 2015 S. Karger GmbH, Freiburg
引用
收藏
页码:413 / 416
页数:4
相关论文
共 50 条
  • [31] Prognostic Value of Total Lesion Glycolysis Measured by 18F-FDG-PET/CT in Patients with Colorectal Cancer
    Ogawa, Shimpei
    Itabashi, Michio
    Kondo, Chisato
    Momose, Mitsuru
    Sakai, Shuji
    Kameoka, Shingo
    ANTICANCER RESEARCH, 2015, 35 (06) : 3495 - 3500
  • [32] Correlation of hypoxia inducible transcription factor in breast cancer and SUVmax of F-18 FDG PET/CT
    Jeong, Y.
    Jung, J.
    Cho, Y.
    Park, S.
    Oh, H.
    Kang, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S271 - S271
  • [33] Prognostic Value of Metabolic Tumor Volume Measured by F-18-FDG PET/ CT in Esophageal Cancer Patients
    Soydal, Cigdem
    Yuksel, Cabir
    Kucuk, Ozlem N.
    Okten, Ilker
    Ozkan, Elgin
    Erdogan, Beyza Doganay
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2014, 23 (01) : 12 - 15
  • [34] Prognostic Value of Metabolic Tumor Volume Measured by 18F-FDG PET/CT in Esophageal Cancer Patients
    Soydal, C.
    Yuksel, C.
    Kucuk, O. N.
    Okten, I.
    Ozkan, E.
    Erdogan, B. Doganay
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S363 - S363
  • [35] Prognostic Value of Metabolic Activity Measured by 18F-FDG PET/CT in Patients with Advanced Endometrial Cancer
    Kim H.J.
    Choi J.
    Jeong Y.H.
    Jo K.H.
    Lee J.-H.
    Cho A.
    Yun M.
    Lee J.D.
    Kim Y.T.
    Kang W.J.
    Nuclear Medicine and Molecular Imaging, 2013, 47 (4) : 257 - 262
  • [36] The prognostic significance of F-18 FLT, F-18 FDG, F-18 FET PET/CT in patients with malignant brain tumor
    Chang, Kyoung Jin
    Lim, Ilhan
    Hwang, Jae-Pil
    Park, Joon Yeun
    Kim, Byung Il
    Yoon, Sang Min
    Chang, In Suk
    Lee, Chang Hoon
    Choi, Chang Woon
    Lim, Sang Moo
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [37] Additional value of MDCT over F-18 FDG-PET/CT in assessment of lymph nodes metastases in patients with esophageal carcinoma
    Ishihara, M.
    Shiiba, M.
    Udagawa, H.
    Maruno, H.
    Ishihara, K.
    Kumita, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S467 - S467
  • [38] Prognostic Role of F-18 FDG PET in Uterine Cervical Cancer Patients: 10 Years Experience
    Soydal, C.
    Baltacioglu, M. H.
    Araz, M.
    Taskin, S.
    Kucuk, N. O.
    Ortac, U. F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S556 - S556
  • [39] Determine the best threshold of SUVmax of the cervical cancer with 18F-FDG PET/CT for its biological target volume
    Wang, Shengjun
    Yang, Weidong
    Wang, Jing
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [40] Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer
    Chung, Hyun Hoon
    Kim, Jae Weon
    Han, Kyung Hee
    Eo, Jae Seon
    Kang, Keon Wook
    Park, Noh-Hyun
    Song, Yong-Sang
    Chung, June-Key
    Kang, Soon-Beom
    GYNECOLOGIC ONCOLOGY, 2011, 120 (02) : 270 - 274